中国神威药业集团有限公司（02877）于2026年1月5日向香港联交所提交截至2025年12月31日的月度证券变动报告。公告显示，公司法定注册股本维持在5,000,000,000股普通股，每股面值为0.1港元，合计5亿港元。
报告期内，已发行股份总数继续稳定在827,000,000股，库藏股份数量保持为0股，未发生任何新增发行、购回或注销操作。同时，公告未显示有关股份期权、股权激励等方面的变动或执行信息。
截至12月31日，公司股本结构保持不变。公司亦在公告中确认，相关发行和股份变动事宜均严格遵守了香港联交所《上市规则》及相关法律要求。
上述月报由公司秘书李品正代表董事会签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.